APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Banking and Blood Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Blood Banking and Blood Products Market Outlook and Growth Opportunities 2026

27 December 2025217 pages

Choose your research edition.

Industry ResearchBlood Banking and Blood Products Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Banking and Blood Products Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Blood Banking and Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Banking and Blood Products Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Banking and Blood Products Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Blood Banking and Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Blood Banking and Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Banking and Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Banking and Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Blood Banking and Blood Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Blood Banking and Blood Products market include Red Cross Society of China, Yuanda Shuyang, Weiguang Bio, Tiantan Bio, CBPO, Shuanglin Bio, RAAS, Nanyue Bio and Hualan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Blood Banking and Blood Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Banking and Blood Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Banking and Blood Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Blood Banking and Blood Products market.

Blood Banking and Blood Products Segment by Company

Red Cross Society of China

Yuanda Shuyang

Weiguang Bio

Tiantan Bio

CBPO

Shuanglin Bio

RAAS

Nanyue Bio

Hualan Bio

Boya Bio

Vitalant

Takeda

Sanquin Blood Supply Foundation

Octapharma

NHS Blood and Transplant

New York Blood Center

National Blood Transfusion Council

LFB Group

KM Biologics

Kedrion

Japan Red Cross Society

Grifols

CSL

Canadian Blood Services

BPL

Blood Bank of Alaska

Biotest

Australia Red Cross

American Red Cross

America’s Blood Centers

Blood Banking and Blood Products Segment by Type

RBCs

Whole Blood

Plasma

Plasma Fractionation Products

Plts

Blood Banking and Blood Products Segment by Application

Clinic

Hospital

Retail Pharmacy

Others

Blood Banking and Blood Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Banking and Blood Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Blood Banking and Blood Products key companies, revenue, market share, and recent developments.

3. To split the Blood Banking and Blood Products breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Blood Banking and Blood Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Banking and Blood Products significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Banking and Blood Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Banking and Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Banking and Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Banking and Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Banking and Blood Products industry.

Chapter 3: Detailed analysis of Blood Banking and Blood Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Blood Banking and Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Blood Banking and Blood Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Banking and Blood Products Industry Trends Table 2. Blood Banking and Blood Products Industry Drivers Table 3. Blood Banking and Blood Products Industry Opportunities and Challenges Table 4. Blood Banking and Blood Products Industry Restraints Table 5. Global Blood Banking and Blood Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Banking and Blood Products Revenue Share by Company (2021-2026) Table 7. Global Blood Banking and Blood Products Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Blood Banking and Blood Products Key Company Manufacturing Base & Headquarters Table 9. Global Blood Banking and Blood Products Company, Product Type & Application Table 10. Global Blood Banking and Blood Products Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Blood Banking and Blood Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of RBCs Table 15. Significant Companies of Whole Blood Table 16. Significant Companies of Plasma Table 17. Significant Companies of Plasma Fractionation Products Table 18. Significant Companies of Plts Table 19. Global Blood Banking and Blood Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Blood Banking and Blood Products Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Blood Banking and Blood Products Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Blood Banking and Blood Products Sales Value Share by Type (2021-2026) Table 23. Global Blood Banking and Blood Products Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Clinic Table 25. Significant Companies of Hospital Table 26. Significant Companies of Retail Pharmacy Table 27. Significant Companies of Others Table 28. Global Blood Banking and Blood Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Blood Banking and Blood Products Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Blood Banking and Blood Products Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Blood Banking and Blood Products Sales Value Share by Application (2021-2026) Table 32. Global Blood Banking and Blood Products Sales Value Share by Application (2027-2032) Table 33. Global Blood Banking and Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Blood Banking and Blood Products Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Blood Banking and Blood Products Sales Value Share by Region (2021-2026) Table 36. Global Blood Banking and Blood Products Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Blood Banking and Blood Products Sales Value Share by Region (2027-2032) Table 38. Global Blood Banking and Blood Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Blood Banking and Blood Products Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Blood Banking and Blood Products Sales Value Market Share by Country (2021-2026) Table 41. Global Blood Banking and Blood Products Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Blood Banking and Blood Products Sales Value Market Share by Country (2027-2032) Table 43. Red Cross Society of China Company Information Table 44. Red Cross Society of China Business Overview Table 45. Red Cross Society of China Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Red Cross Society of China Blood Banking and Blood Products Product Portfolio Table 47. Red Cross Society of China Recent Development Table 48. Yuanda Shuyang Company Information Table 49. Yuanda Shuyang Business Overview Table 50. Yuanda Shuyang Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Yuanda Shuyang Blood Banking and Blood Products Product Portfolio Table 52. Yuanda Shuyang Recent Development Table 53. Weiguang Bio Company Information Table 54. Weiguang Bio Business Overview Table 55. Weiguang Bio Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Weiguang Bio Blood Banking and Blood Products Product Portfolio Table 57. Weiguang Bio Recent Development Table 58. Tiantan Bio Company Information Table 59. Tiantan Bio Business Overview Table 60. Tiantan Bio Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Tiantan Bio Blood Banking and Blood Products Product Portfolio Table 62. Tiantan Bio Recent Development Table 63. CBPO Company Information Table 64. CBPO Business Overview Table 65. CBPO Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. CBPO Blood Banking and Blood Products Product Portfolio Table 67. CBPO Recent Development Table 68. Shuanglin Bio Company Information Table 69. Shuanglin Bio Business Overview Table 70. Shuanglin Bio Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shuanglin Bio Blood Banking and Blood Products Product Portfolio Table 72. Shuanglin Bio Recent Development Table 73. RAAS Company Information Table 74. RAAS Business Overview Table 75. RAAS Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. RAAS Blood Banking and Blood Products Product Portfolio Table 77. RAAS Recent Development Table 78. Nanyue Bio Company Information Table 79. Nanyue Bio Business Overview Table 80. Nanyue Bio Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Nanyue Bio Blood Banking and Blood Products Product Portfolio Table 82. Nanyue Bio Recent Development Table 83. Hualan Bio Company Information Table 84. Hualan Bio Business Overview Table 85. Hualan Bio Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Hualan Bio Blood Banking and Blood Products Product Portfolio Table 87. Hualan Bio Recent Development Table 88. Boya Bio Company Information Table 89. Boya Bio Business Overview Table 90. Boya Bio Blood Banking and Blood Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Boya Bio Blood Banking and Blood Products Product Portfolio Table 92. Boya Bio Recent Development Table 93. Vitalant Company Information Table 94. Vitalant Business Overview Table 95. Vitalant Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Vitalant Blood Banking and Blood Products Product Portfolio Table 97. Vitalant Recent Development Table 98. Takeda Company Information Table 99. Takeda Business Overview Table 100. Takeda Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Takeda Blood Banking and Blood Products Product Portfolio Table 102. Takeda Recent Development Table 103. Sanquin Blood Supply Foundation Company Information Table 104. Sanquin Blood Supply Foundation Business Overview Table 105. Sanquin Blood Supply Foundation Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio Table 107. Sanquin Blood Supply Foundation Recent Development Table 108. Octapharma Company Information Table 109. Octapharma Business Overview Table 110. Octapharma Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Octapharma Blood Banking and Blood Products Product Portfolio Table 112. Octapharma Recent Development Table 113. NHS Blood and Transplant Company Information Table 114. NHS Blood and Transplant Business Overview Table 115. NHS Blood and Transplant Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio Table 117. NHS Blood and Transplant Recent Development Table 118. New York Blood Center Company Information Table 119. New York Blood Center Business Overview Table 120. New York Blood Center Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. New York Blood Center Blood Banking and Blood Products Product Portfolio Table 122. New York Blood Center Recent Development Table 123. National Blood Transfusion Council Company Information Table 124. National Blood Transfusion Council Business Overview Table 125. National Blood Transfusion Council Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio Table 127. National Blood Transfusion Council Recent Development Table 128. LFB Group Company Information Table 129. LFB Group Business Overview Table 130. LFB Group Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. LFB Group Blood Banking and Blood Products Product Portfolio Table 132. LFB Group Recent Development Table 133. KM Biologics Company Information Table 134. KM Biologics Business Overview Table 135. KM Biologics Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. KM Biologics Blood Banking and Blood Products Product Portfolio Table 137. KM Biologics Recent Development Table 138. Kedrion Company Information Table 139. Kedrion Business Overview Table 140. Kedrion Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Kedrion Blood Banking and Blood Products Product Portfolio Table 142. Kedrion Recent Development Table 143. Japan Red Cross Society Company Information Table 144. Japan Red Cross Society Business Overview Table 145. Japan Red Cross Society Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Japan Red Cross Society Blood Banking and Blood Products Product Portfolio Table 147. Japan Red Cross Society Recent Development Table 148. Grifols Company Information Table 149. Grifols Business Overview Table 150. Grifols Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Grifols Blood Banking and Blood Products Product Portfolio Table 152. Grifols Recent Development Table 153. CSL Company Information Table 154. CSL Business Overview Table 155. CSL Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. CSL Blood Banking and Blood Products Product Portfolio Table 157. CSL Recent Development Table 158. Canadian Blood Services Company Information Table 159. Canadian Blood Services Business Overview Table 160. Canadian Blood Services Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Canadian Blood Services Blood Banking and Blood Products Product Portfolio Table 162. Canadian Blood Services Recent Development Table 163. BPL Company Information Table 164. BPL Business Overview Table 165. BPL Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. BPL Blood Banking and Blood Products Product Portfolio Table 167. BPL Recent Development Table 168. Blood Bank of Alaska Company Information Table 169. Blood Bank of Alaska Business Overview Table 170. Blood Bank of Alaska Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio Table 172. Blood Bank of Alaska Recent Development Table 173. Biotest Company Information Table 174. Biotest Business Overview Table 175. Biotest Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. Biotest Blood Banking and Blood Products Product Portfolio Table 177. Biotest Recent Development Table 178. Australia Red Cross Company Information Table 179. Australia Red Cross Business Overview Table 180. Australia Red Cross Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 181. Australia Red Cross Blood Banking and Blood Products Product Portfolio Table 182. Australia Red Cross Recent Development Table 183. American Red Cross Company Information Table 184. American Red Cross Business Overview Table 185. American Red Cross Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 186. American Red Cross Blood Banking and Blood Products Product Portfolio Table 187. American Red Cross Recent Development Table 188. America’s Blood Centers Company Information Table 189. America’s Blood Centers Business Overview Table 190. America’s Blood Centers Blood Banking and Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 191. America’s Blood Centers Blood Banking and Blood Products Product Portfolio Table 192. America’s Blood Centers Recent Development Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Blood Banking and Blood Products Product Image Figure 2. Global Blood Banking and Blood Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Banking and Blood Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Banking and Blood Products Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. RBCs Image Figure 8. Whole Blood Image Figure 9. Plasma Image Figure 10. Plasma Fractionation Products Image Figure 11. Plts Image Figure 12. Global Blood Banking and Blood Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Blood Banking and Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Blood Banking and Blood Products Sales Value Share by Type (2021-2032) Figure 15. Clinic Image Figure 16. Hospital Image Figure 17. Retail Pharmacy Image Figure 18. Others Image Figure 19. Global Blood Banking and Blood Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Blood Banking and Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Blood Banking and Blood Products Sales Value Share by Application (2021-2032) Figure 22. Global Blood Banking and Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Blood Banking and Blood Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 25. North America Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 31. South America Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Blood Banking and Blood Products Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Blood Banking and Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Blood Banking and Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • RBCs
  • Whole Blood
  • Plasma
  • Plasma Fractionation Products
  • Plts
Applications
  • Clinic
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Red Cross Society of China
  • Yuanda Shuyang
  • Weiguang Bio
  • Tiantan Bio
  • CBPO
  • Shuanglin Bio
  • RAAS
  • Nanyue Bio
  • Hualan Bio
  • Boya Bio
  • Vitalant
  • Takeda
  • Sanquin Blood Supply Foundation
  • Octapharma
  • NHS Blood and Transplant
  • New York Blood Center
  • National Blood Transfusion Council
  • LFB Group
  • KM Biologics
  • Kedrion
  • Japan Red Cross Society
  • Grifols
  • CSL
  • Canadian Blood Services
  • BPL
  • Blood Bank of Alaska
  • Biotest
  • Australia Red Cross
  • American Red Cross
  • America’s Blood Centers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood Banking and Blood Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood Banking and Blood Products Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Blood Banking and Blood Products Market Dynamics
  1. 2.1 Blood Banking and Blood Products Industry Trends
  2. 2.2 Blood Banking and Blood Products Industry Drivers
  3. 2.3 Blood Banking and Blood Products Industry Opportunities and Challenges
  4. 2.4 Blood Banking and Blood Products Industry Restraints
3 Blood Banking and Blood Products Market by Company
  1. 3.1 Global Blood Banking and Blood Products Company Revenue Ranking in 2025
  2. 3.2 Global Blood Banking and Blood Products Revenue by Company (2021-2026)
  3. 3.3 Global Blood Banking and Blood Products Company Ranking (2024-2026)
  4. 3.4 Global Blood Banking and Blood Products Company Manufacturing Base and Headquarters
  5. 3.5 Global Blood Banking and Blood Products Company Product Type and Application
  6. 3.6 Global Blood Banking and Blood Products Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Blood Banking and Blood Products Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Blood Banking and Blood Products Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Blood Banking and Blood Products Market by Type
  1. 4.1 Blood Banking and Blood Products Type Introduction
  2. 4.1.1 RBCs
  3. 4.1.2 Whole Blood
  4. 4.1.3 Plasma
  5. 4.1.4 Plasma Fractionation Products
  6. 4.1.5 Plts
  7. 4.2 Global Blood Banking and Blood Products Sales Value by Type
  8. 4.2.1 Global Blood Banking and Blood Products Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Blood Banking and Blood Products Sales Value by Type (2021-2032)
  10. 4.2.3 Global Blood Banking and Blood Products Sales Value Share by Type (2021-2032)
5 Blood Banking and Blood Products Market by Application
  1. 5.1 Blood Banking and Blood Products Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Retail Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Blood Banking and Blood Products Sales Value by Application
  7. 5.2.1 Global Blood Banking and Blood Products Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Blood Banking and Blood Products Sales Value by Application (2021-2032)
  9. 5.2.3 Global Blood Banking and Blood Products Sales Value Share by Application (2021-2032)
6 Blood Banking and Blood Products Regional Value Analysis
  1. 6.1 Global Blood Banking and Blood Products Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Banking and Blood Products Sales Value by Region (2021-2032)
  3. 6.2.1 Global Blood Banking and Blood Products Sales Value by Region: 2021-2026
  4. 6.2.2 Global Blood Banking and Blood Products Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood Banking and Blood Products Sales Value (2021-2032)
  7. 6.3.2 North America Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Blood Banking and Blood Products Sales Value (2021-2032)
  10. 6.4.2 Europe Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Blood Banking and Blood Products Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Blood Banking and Blood Products Sales Value (2021-2032)
  16. 6.6.2 South America Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Blood Banking and Blood Products Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Blood Banking and Blood Products Sales Value Share by Country, 2025 VS 2032
7 Blood Banking and Blood Products Country-level Value Analysis
  1. 7.1 Global Blood Banking and Blood Products Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Banking and Blood Products Sales Value by Country (2021-2032)
  3. 7.2.1 Global Blood Banking and Blood Products Sales Value by Country (2021-2026)
  4. 7.2.2 Global Blood Banking and Blood Products Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Blood Banking and Blood Products Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Blood Banking and Blood Products Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Blood Banking and Blood Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Red Cross Society of China
  2. 8.1.1 Red Cross Society of China Company Information
  3. 8.1.2 Red Cross Society of China Business Overview
  4. 8.1.3 Red Cross Society of China Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Red Cross Society of China Blood Banking and Blood Products Product Portfolio
  6. 8.1.5 Red Cross Society of China Recent Developments
  7. 8.2 Yuanda Shuyang
  8. 8.2.1 Yuanda Shuyang Company Information
  9. 8.2.2 Yuanda Shuyang Business Overview
  10. 8.2.3 Yuanda Shuyang Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Yuanda Shuyang Blood Banking and Blood Products Product Portfolio
  12. 8.2.5 Yuanda Shuyang Recent Developments
  13. 8.3 Weiguang Bio
  14. 8.3.1 Weiguang Bio Company Information
  15. 8.3.2 Weiguang Bio Business Overview
  16. 8.3.3 Weiguang Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Weiguang Bio Blood Banking and Blood Products Product Portfolio
  18. 8.3.5 Weiguang Bio Recent Developments
  19. 8.4 Tiantan Bio
  20. 8.4.1 Tiantan Bio Company Information
  21. 8.4.2 Tiantan Bio Business Overview
  22. 8.4.3 Tiantan Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tiantan Bio Blood Banking and Blood Products Product Portfolio
  24. 8.4.5 Tiantan Bio Recent Developments
  25. 8.5 CBPO
  26. 8.5.1 CBPO Company Information
  27. 8.5.2 CBPO Business Overview
  28. 8.5.3 CBPO Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CBPO Blood Banking and Blood Products Product Portfolio
  30. 8.5.5 CBPO Recent Developments
  31. 8.6 Shuanglin Bio
  32. 8.6.1 Shuanglin Bio Company Information
  33. 8.6.2 Shuanglin Bio Business Overview
  34. 8.6.3 Shuanglin Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shuanglin Bio Blood Banking and Blood Products Product Portfolio
  36. 8.6.5 Shuanglin Bio Recent Developments
  37. 8.7 RAAS
  38. 8.7.1 RAAS Company Information
  39. 8.7.2 RAAS Business Overview
  40. 8.7.3 RAAS Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  41. 8.7.4 RAAS Blood Banking and Blood Products Product Portfolio
  42. 8.7.5 RAAS Recent Developments
  43. 8.8 Nanyue Bio
  44. 8.8.1 Nanyue Bio Company Information
  45. 8.8.2 Nanyue Bio Business Overview
  46. 8.8.3 Nanyue Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nanyue Bio Blood Banking and Blood Products Product Portfolio
  48. 8.8.5 Nanyue Bio Recent Developments
  49. 8.9 Hualan Bio
  50. 8.9.1 Hualan Bio Company Information
  51. 8.9.2 Hualan Bio Business Overview
  52. 8.9.3 Hualan Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hualan Bio Blood Banking and Blood Products Product Portfolio
  54. 8.9.5 Hualan Bio Recent Developments
  55. 8.10 Boya Bio
  56. 8.10.1 Boya Bio Company Information
  57. 8.10.2 Boya Bio Business Overview
  58. 8.10.3 Boya Bio Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boya Bio Blood Banking and Blood Products Product Portfolio
  60. 8.10.5 Boya Bio Recent Developments
  61. 8.11 Vitalant
  62. 8.11.1 Vitalant Company Information
  63. 8.11.2 Vitalant Business Overview
  64. 8.11.3 Vitalant Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Vitalant Blood Banking and Blood Products Product Portfolio
  66. 8.11.5 Vitalant Recent Developments
  67. 8.12 Takeda
  68. 8.12.1 Takeda Company Information
  69. 8.12.2 Takeda Business Overview
  70. 8.12.3 Takeda Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Takeda Blood Banking and Blood Products Product Portfolio
  72. 8.12.5 Takeda Recent Developments
  73. 8.13 Sanquin Blood Supply Foundation
  74. 8.13.1 Sanquin Blood Supply Foundation Company Information
  75. 8.13.2 Sanquin Blood Supply Foundation Business Overview
  76. 8.13.3 Sanquin Blood Supply Foundation Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sanquin Blood Supply Foundation Blood Banking and Blood Products Product Portfolio
  78. 8.13.5 Sanquin Blood Supply Foundation Recent Developments
  79. 8.14 Octapharma
  80. 8.14.1 Octapharma Company Information
  81. 8.14.2 Octapharma Business Overview
  82. 8.14.3 Octapharma Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Octapharma Blood Banking and Blood Products Product Portfolio
  84. 8.14.5 Octapharma Recent Developments
  85. 8.15 NHS Blood and Transplant
  86. 8.15.1 NHS Blood and Transplant Company Information
  87. 8.15.2 NHS Blood and Transplant Business Overview
  88. 8.15.3 NHS Blood and Transplant Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  89. 8.15.4 NHS Blood and Transplant Blood Banking and Blood Products Product Portfolio
  90. 8.15.5 NHS Blood and Transplant Recent Developments
  91. 8.16 New York Blood Center
  92. 8.16.1 New York Blood Center Company Information
  93. 8.16.2 New York Blood Center Business Overview
  94. 8.16.3 New York Blood Center Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  95. 8.16.4 New York Blood Center Blood Banking and Blood Products Product Portfolio
  96. 8.16.5 New York Blood Center Recent Developments
  97. 8.17 National Blood Transfusion Council
  98. 8.17.1 National Blood Transfusion Council Company Information
  99. 8.17.2 National Blood Transfusion Council Business Overview
  100. 8.17.3 National Blood Transfusion Council Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  101. 8.17.4 National Blood Transfusion Council Blood Banking and Blood Products Product Portfolio
  102. 8.17.5 National Blood Transfusion Council Recent Developments
  103. 8.18 LFB Group
  104. 8.18.1 LFB Group Company Information
  105. 8.18.2 LFB Group Business Overview
  106. 8.18.3 LFB Group Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  107. 8.18.4 LFB Group Blood Banking and Blood Products Product Portfolio
  108. 8.18.5 LFB Group Recent Developments
  109. 8.19 KM Biologics
  110. 8.19.1 KM Biologics Company Information
  111. 8.19.2 KM Biologics Business Overview
  112. 8.19.3 KM Biologics Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  113. 8.19.4 KM Biologics Blood Banking and Blood Products Product Portfolio
  114. 8.19.5 KM Biologics Recent Developments
  115. 8.20 Kedrion
  116. 8.20.1 Kedrion Company Information
  117. 8.20.2 Kedrion Business Overview
  118. 8.20.3 Kedrion Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Kedrion Blood Banking and Blood Products Product Portfolio
  120. 8.20.5 Kedrion Recent Developments
  121. 8.21 Japan Red Cross Society
  122. 8.21.1 Japan Red Cross Society Company Information
  123. 8.21.2 Japan Red Cross Society Business Overview
  124. 8.21.3 Japan Red Cross Society Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Japan Red Cross Society Blood Banking and Blood Products Product Portfolio
  126. 8.21.5 Japan Red Cross Society Recent Developments
  127. 8.22 Grifols
  128. 8.22.1 Grifols Company Information
  129. 8.22.2 Grifols Business Overview
  130. 8.22.3 Grifols Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Grifols Blood Banking and Blood Products Product Portfolio
  132. 8.22.5 Grifols Recent Developments
  133. 8.23 CSL
  134. 8.23.1 CSL Company Information
  135. 8.23.2 CSL Business Overview
  136. 8.23.3 CSL Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  137. 8.23.4 CSL Blood Banking and Blood Products Product Portfolio
  138. 8.23.5 CSL Recent Developments
  139. 8.24 Canadian Blood Services
  140. 8.24.1 Canadian Blood Services Company Information
  141. 8.24.2 Canadian Blood Services Business Overview
  142. 8.24.3 Canadian Blood Services Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Canadian Blood Services Blood Banking and Blood Products Product Portfolio
  144. 8.24.5 Canadian Blood Services Recent Developments
  145. 8.25 BPL
  146. 8.25.1 BPL Company Information
  147. 8.25.2 BPL Business Overview
  148. 8.25.3 BPL Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  149. 8.25.4 BPL Blood Banking and Blood Products Product Portfolio
  150. 8.25.5 BPL Recent Developments
  151. 8.26 Blood Bank of Alaska
  152. 8.26.1 Blood Bank of Alaska Company Information
  153. 8.26.2 Blood Bank of Alaska Business Overview
  154. 8.26.3 Blood Bank of Alaska Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Blood Bank of Alaska Blood Banking and Blood Products Product Portfolio
  156. 8.26.5 Blood Bank of Alaska Recent Developments
  157. 8.27 Biotest
  158. 8.27.1 Biotest Company Information
  159. 8.27.2 Biotest Business Overview
  160. 8.27.3 Biotest Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Biotest Blood Banking and Blood Products Product Portfolio
  162. 8.27.5 Biotest Recent Developments
  163. 8.28 Australia Red Cross
  164. 8.28.1 Australia Red Cross Company Information
  165. 8.28.2 Australia Red Cross Business Overview
  166. 8.28.3 Australia Red Cross Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Australia Red Cross Blood Banking and Blood Products Product Portfolio
  168. 8.28.5 Australia Red Cross Recent Developments
  169. 8.29 American Red Cross
  170. 8.29.1 American Red Cross Company Information
  171. 8.29.2 American Red Cross Business Overview
  172. 8.29.3 American Red Cross Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  173. 8.29.4 American Red Cross Blood Banking and Blood Products Product Portfolio
  174. 8.29.5 American Red Cross Recent Developments
  175. 8.30 America’s Blood Centers
  176. 8.30.1 America’s Blood Centers Company Information
  177. 8.30.2 America’s Blood Centers Business Overview
  178. 8.30.3 America’s Blood Centers Blood Banking and Blood Products Revenue and Gross Margin (2021-2026)
  179. 8.30.4 America’s Blood Centers Blood Banking and Blood Products Product Portfolio
  180. 8.30.5 America’s Blood Centers Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst